There are 2789 resources available
1538P - Germline testing of sarcoma revealed frequent mutations in genes involved in DNA repair, RNA metabolism, and epigenetic regulation
Presenter: Haicheng Gao
Session: ePoster Display
1539P - Sarcomas in the Dutch LFS population: Data from the national screening of TP53 germline mutation carriers at the Netherlands Cancer Institute
Presenter: Gijsbrecht de Wit
Session: ePoster Display
1540P - Ripretinib as ≥4th-line treatment in patients with advanced gastrointestinal stromal tumor: Long-term update from the phase III INVICTUS study
Presenter: Margaret von Mehren
Session: ePoster Display
1541P - Real-world data from patients with gastrointestinal stromal tumors (GIST) treated in Dutch GIST expertise centers
Presenter: Nikki IJzerman
Session: ePoster Display
1542P - Kaposi sarcoma: A population-based study of secondary primary neoplasms
Presenter: Gabriel Hanna
Session: ePoster Display
Resources:
Abstract
1543P - Gemcitabine in classic Kaposi’s sarcoma: A pilot study
Presenter: Giuseppe Badalamenti
Session: ePoster Display
1544P - Soft tissue sarcoma (STS) incidences and clinical characteristics are significantly different between different geographic and ethnic populations
Presenter: Tom Wei-Wu Chen
Session: ePoster Display
1466P - Napabucasin + nab-paclitaxel with gemcitabine in patients (pts) with metastatic pancreatic adenocarcinoma (mPDAC): Results from the phase III CanStem111P study
Presenter: Tanios Bekaii-Saab
Session: ePoster Display
1467P - POLO: Long-term safety and tolerability of olaparib for patients with a germline BRCA mutation and metastatic pancreatic cancer
Presenter: Dirk Arnold
Session: ePoster Display
1468P - POLO: Subsequent therapy after maintenance olaparib in patients with a germline BRCA mutation and metastatic pancreatic cancer
Presenter: Talia Golan
Session: ePoster Display